Cambridge Orthopaedic Labs

Cambridge Orthopaedic Labs is a private Anglo-American orthopedic medical device company focused on non-invasive trauma fixation technologies. Its lead commercial product platform, PolyArmour, is a patented non-invasive external fracture fixation system designed to treat broken bones while reducing or avoiding invasive surgery. The company states that its technology is intended to improve patient outcomes and accelerate mobility, with an initial focus on wrist fractures and related orthopedic applications such as deformity correction and soft tissue stabilisation. Cambridge Orthopaedic Labs received FDA clearance for PolyArmour in 2022 and announced its first commercial use in 2023 in the United States. The business appears to operate as an early commercial-stage orthopedic device developer rather than a drug-development biotech company.